Avantor, Inc. (AVTR): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Avantor, Inc. (AVTR) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EXHIBIT 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE Avantor appoints new Chief Financial Officer RADNOR, Pa. – September 21, 2026 – Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technolog

Event · Exec change
Person
Todd Garner
Title
Executive Vice President and Chief Financial Officer
Action
appointed
Effective
September 21, 2026
Predecessor
Steve Eck

Facts are quoted from the filing text and checked against it.

Original reporting
Published Sep 21, 2026, 11:14 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 11:18 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$AVTR
Neutral
medium confidence
Mentioned
$AVTR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AVTRNeutralMed
01

Why it matters

The filing provides the first public disclosure of the CFO transition, a corporate action that may affect valuation and analyst coverage.

02

Market read

Executive leadership updates are material corporate actions; investors may reassess Avantor's financial strategy.

03

What to watch

Todd Garner's experience at Conmed and C.R. Bard may bring operational efficiencies not yet priced in.

Relevance 6/10Novelty 6/10Timing: effective Sep 21 2026

Background

SEC Form 8‑K filed by Avantor (NYSE: AVTR) details the appointment of a new CFO and the continuation of the interim CFO in his prior role.

Company-level read

Ticker impact

$AVTRNeutralMedium confidence
Context

Avantor filed an 8‑K announcing Todd Garner as its new Executive Vice President and Chief Financial Officer, effective September 21, 2026.

Expected impact

Potential modest upside if market views the hire positively; downside risk if investors see it as a response to prior performance issues.

Evidence & confidence

Executive changes are material but typically do not cause immediate large price moves; impact depends on market sentiment toward the new CFO's background.

Market effects

Leadership change may influence life‑science tools sector expectations for cost management and growth execution.

Limited to U.S. and global investors tracking Avantor; no broader regional effect.

Minimal; primarily relevant to Avantor shareholders and sector analysts.

Counterpoint

The CFO change could be a red flag indicating internal challenges, suggesting a short‑term pullback.

Key entities

  • Todd Garner

    New Executive Vice President and Chief Financial Officer of Avantor.

  • Steve Eck

    Current Senior Vice President and Chief Accounting Officer, serving as interim CFO.

Related articles

$AVTRMedAI 8/10

Avantor Inc (AVTR) Q3 2026 Earnings Call Highlights: Return to Organic Growth, Raised

Avantor Inc (AVTR) reported Q3 2026 earnings, highlighting organic growth and raised guidance. CEO Emmanuel Ligner expressed confidence in 2027, citing strong momentum. CFO Todd Garner forecasted Q4 revenue growth of 2.5% to 4.5%, with VWR growing mid-single-digits. AI is seen as a potential tailwind. Margins faced pressure from mix and inflation, but EBITDA margin expansion is expected to continue. Investments in facilities and AI tools are ongoing, with returns anticipated over time.

$AVTRHighAI 8/10

What Avantor (AVTR) Said on Its Q3 Earnings Call

Avantor (AVTR) reported Q3 revenue of $465M for its Bioscience & Medtech Products segment, up 3.6% organically. Adjusted operating income was $123M with a 26.6% margin. The company raised its 2026 organic revenue growth outlook to 0.75-1.25% and increased its adjusted EPS and free cash flow projections. Avantor aims to reduce net leverage below 3x by year-end.

$AVTRHighAI 8/10

Avantor (AVTR) Q3 2026 Earnings Call Transcript

Avantor (AVTR) reported Q3 2026 earnings, exceeding expectations with $1.698B revenue (5.2% organic growth) and $0.22 adjusted EPS. VWR and BMP segments showed strong performance, driving growth. The company raised full-year guidance and aims to reduce leverage below 3x by year-end. Revival initiatives are improving execution and end-market demand.